First-in-Human, Phase 1 Study of PHN-012, an Antibody Drug Conjugate, in Patients With Advanced Solid Tumors
NCT07127874 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Pheon Therapeutics. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Pheon Therapeutics.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Pheon Therapeutics currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Pheon Therapeutics conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Pheon Therapeutics currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.